Pharma Sales Excellence
Pharma Sales Excellence
Pharma Sales Excellence
Barcelona, Spain
2
A. The need to change pharmaceutical sales and marketing
18,000
15,000
12,000
• Over 60% growth of European
pharma sales reps during last 5
years, especially in Spain and Italy
UK Germany France
• ≈100.000 sales reps in Europe
represent 80% of promotional spent
18
UK Germany France
"The days of armies of sales reps in the field driving revenues are over. It will no longer be
about numbers and volume. Now the focus will shift to productivity and performance of the
sales staff who remains."
April 15, 2005
Change focus
Constant change
5 Kick-start implementation drives relentless 1 Frame the change scope
execution
Drive the change through local Select the levers to be addressed
general managers and their teams based on concrete analysis
5 1
Country
Across countries
Regional/
global • Quantitative internal sales benchmarking 1
• Roland Berger sales force effectiveness model 2
Bottom-up in a country
Policy maker
Payor/
formulary
Physician
No differentiated
approach to regional Pharmacist
Under-developed
authorities
KAM approach to
Patients
payors Lacking KAM
approach for mid- No pharmacy
sized hospitals franchise Brand awareness/
concept consumer involvement
OPinion
underutilized/not
leaders leveraged
Regional opinion
leaders not targeted
sufficiently
• Prescriptions share
Efficiency/
effectiveness • Prescriptions on EUR 1 of M&S investment
• Prescriptions per sales rep
• Call productivity index1)
• Fraction of sales reps to total country FTEs Analyze
combined
effects of
Costs • Costs per sales rep selected cost
benchmarks Factor costs
• Price index (of prescriptions)2) benchmarks
across
countries
• Potential per covered doctor
Structure
• Annual calls per rep in country
Accepted frequency by physicians
1) Annual calls per rep compared to industry average 2) Only relevant for costs comparisons relative to sales
Low High
1 2 3 4
Targeting
Organization
& size
Metrics
Qualitative evaluation
• Call allocation ratio
• Targeting effectiveness ratio 2
• Number of application studies 4 0/4 1/4 2/4 3/4 4/4 5/4 6/4
• Usage of central events
3 3 0/3 1/3 2/3 3/3 4/3 5/3 6/3
Qualitative criteria
4 2 0/2 1/2 2/2 3/2 4/2 5/2 6/2
• Results orientation
• Customer orientation 1 0/1 1/1 2/1 3/1 4/1 5/1 6/1
• Expertise 5
• Self-assurance
• Self-initiation 0 0/0 1/0 2/0 3/0 4/0 5/0 6/0
• Teaming 6
• Communication Performance Performance Performance Performance
group 4 group 3 group 2 group 1
• Reach
• Frequency
• Define segmentation criteria to • Define a specific coverage • Define an overall process with a
select the most profitable strategy for each segment clear vision, purpose and value
customers (e.g. concentration
curve based on potential) • Formulate reach and frequency • Install a cross-functional team
objectives per segment to execute the process
• Document and review the future
potential of customers regularly • Monitor execution by segment • Monitor the effects of targeting
on a regular base at sales rep/team level
• Cluster the customers and continuously
address them consistently as
segments
Understand physicians
Formalize call preparation prescribing behavior
Introduce a formalized
coaching Invest into selling skills
B Account-per-account execution
Implementation of clearly defined sales campaigns
based on concrete action plans per team
A B C
Perform gap analysis Prioritize initiatives Define action plans
2 … …
III
Low priority Low hanging 3 … …
… "do later" fruits "should
… do"
Ease of implementation
Proven track record with Tried-and-tested methodologies and tools provided at no costs
vast pharma sales (e.g. Roland Berger assessment database, healthcare 6-P analysis)
experience
Pharma industry and Numerous projects in pharma industry help us understand the problems
process expertise fast and derive workable solutions, (e.g. pan-European launch strategy)
General sales and Our Competence Center Marketing & Sales serves as a platform for global
marketing expertise best practice solutions (e.g. quantitative sales benchmarking)
Strong healthcare We are driving the transformations of national healthcare systems across
knowledge Europe working for leading payors and providers
Our tools, project methodology and teams help deal with complexity fast
Able to manage complexity
and efficiently as more than 900 corporate transformation projects testify
Mature and highly skilled We know the specifics of the pharmaceuticals and healthcare market and
team can still provide an outside-in perspective
Source: Roland Berger 24
Our key to success: Interdisciplinary consulting teams
Engineered
Products &
Healthcare
Chemicals
Consumer
High Tech
Pharma &
Financial
portation
Goods &
Services
INDUSTRY
Services
InfoCom
Utilities
motive
Trans-
Public
CC
Retail
Auto-
& Oil
FUNC-
TIONAL CC
Corp. Strategy &
Organization
Information
Management
Operations
Strategy
Restructuring &
Corporate Finance
Identified funding gap addressed by a comprehensive action plan approved by advisory board
Creativity1)
Experience1)
64%
39% 33%
Implementation
success2)